AEON Biopharma AEON
NYSE AEON
$0.24 0.00 (-1.64%)
As of: Oct 22, 2026 · 10:57 AM EDT

AEON Biopharma (AEON) Change in Other Operating Liabilities (2021 - 2022)

Updated

Analysis

AEON Biopharma (AEON) Change in Other Operating Liabilities (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,171.06 Bn 1,139.65 Bn 19.71 Bn -
2 Johnson & Johnson 634.89 Bn 553.42 Bn 17.26 Bn -972.00 Mn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn -
4 Merck 377.44 Bn 331.82 Bn 12.21 Bn -
5 Novartis Ag 303.91 Bn 267.90 Bn 11.24 Bn -
6 Astrazeneca 267.03 Bn 240.72 Bn 12.86 Bn -
7 Amgen 241.88 Bn 197.28 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 194.01 Bn 168.20 Bn 6.22 Bn -
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -112.00 Mn
10 AEON Biopharma 11.94 Mn -8.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 117,128.00
Sep 30, 2022 287,273.00
Dec 31, 2021 50,000.00
Sep 30, 2021 50,000.00
Jun 30, 2021 50,000.00
Mar 31, 2021 50,000.00
API Access

AEON Biopharma Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=AEON&period=max&api_key=YOUR_API_KEY